Physical Pain and Emotional Suffering: The Case for Palliative Sedation

Journal of Pain

Volumn 10, Issue 3, 2009, Pages 238-242

  Sanft, Tara ^a   Hauser, Joshua ^a   Rosielle, Drew ^a   Weissman, David ^a   Elsayem, Ahmed ^a   Zhukovsky, Donna S ^a   Coyle, Nessa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZODIAZEPINE; CLONAZEPAM; DANTROLENE; FENTANYL; FLUMAZENIL; HYDROMORPHONE; METHADONE; MIDAZOLAM; MORPHINE; OPIATE DERIVATIVE; OXYCODONE;

ADD ON THERAPY; ARTICLE; CENTRAL NERVOUS SYSTEM; COMORBIDITY; DISTRESS SYNDROME; DOSE CALCULATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; EMOTION; ETHICAL DECISION MAKING; HUMAN; HYPERALGESIA; KIDNEY FAILURE; LOW DRUG DOSE; MYOCLONUS; OVARY CANCER; OVARY METASTASIS; PAIN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHYSICIAN; RISK BENEFIT ANALYSIS; RISK FACTOR; SEDATION; SYMPTOMATOLOGY;

CONSCIOUS SEDATION; EMOTIONS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MIDDLE AGED; OVARIAN NEOPLASMS; PAIN; PALLIATIVE CARE; TERMINAL CARE;

EID: 60849122216     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.10.004     Document Type: Article

References (32)

1. AmericanAcademy of Hospice and Palliative Medicine: Statement on Palliative Sedation. Available at: www.aahpm.org/position/sedation/html. Accessed September 2006
2. Benitez-Rosario M.A., Feria M., Salinas-Martin A., and Martinez-Castillo L.P. Martin-Ortega JJ: Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 101 (2004) 2866-2873
3. Brody H. Stories of sickness (1987), Yale University Press, New Haven, CT pp xiii, 210
4. Cassel E.J. The nature of suffering and the goals of medicine. N Engl J Med 306 (1982) 639-645
5. Cassell E.J. Diagnosing suffering: A perspective. Ann Intern Med 131 (1999) 531-534
6. Caviness J.N. Myoclonus. Mayo Clin Proc 71 (1996) 679-688
7. Chater S., Viola R., Paterson J., and Jarvis V. Sedation for intractable distress in the dying: A survey of experts. Palliat Med 12 (1998) 255-269
8. Cherny N.I., and Portenoy R.K. Sedation in the management of refractory symptoms: Guidelines for evaluation and treatment. J Palliat Care 10 (1994) 31-38
9. Coyle N. The existential slap: A crisis of disclosure. Int J Palliat Nurs 10 (2004) 520
10. de Graeff A., and Dean M. Palliative sedation therapy in the last weeks of life: A literature review and recommendations for standards. J Palliat Med 10 (2007) 67-85
11. Doka K.J. Living With Grief: Before and After the Death (2007), Hospice Foundation of America, Washington, DC
12. Fainsinger R.L., Waller A., Bercovici M., Bengtson K., Landman W., and Hosking M. Nunez-Olarte JM, deMoissac D: A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 14 (2000) 257-265
13. Ferrell B.R., and Coyle N. The nature of suffering and the goals of nursing. Oncol Nurs Forum 35 (2008) 241-247
14. Ferris F.D., Balfour H.M., Bowen K., Farley J., Hardwick M., Lamontagne C., Lundy M., Syme A., and West P.J. A model to guide patient and family care: Based on nationally accepted principles and norms of practice. J Pain Sympt Manage 24 (2002) 106-123
15. Field M.J., and Cassel C.K. Institute of Medicine (US). Committee on Care at the End of Life: Approaching death: Improving care at the end of life (1997), National Academy Press, Washington, DC pp xvii, 437
16. Frankl V.E. Man's Search for Meaning: An Introduction to Logotherapy (1963), Beacon Press, Boston, MA p 142
17. Levy M.H., and Cohen S.D. Sedation for the relief of refractory symptoms in the imminently dying: A fine intentional line. Semin Oncol 32 (2005) 237-246
18. Kearney M, Mount B: Spiritual care of the dying, in Chochinov H.M, Breitbart W (eds): Handbook of Psychiatry in Palliative Medicine. Oxford, NY, 2000, pp 357-373.
19. Mercadante S. Dantrolene treatment of opioid-induced myoclonus. Anesth Analg 81 (1995) 1307-1308
20. Mercadante S. Pathophysiology and treatment of opioid-related myoclonus in cancer patients. Pain 74 (1998) 5-9
21. Mercadante S., and Bruera E. Opioid switching: A systematic and critical review. Cancer Treat Rev 32 (2006) 304-315
22. Morita T., Bito S., Kurihara Y., and Uchitomi Y. Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med 8 (2005) 716-729
23. Okon T.R., and George M.L. Fentanyl-induced neurotoxicity and paradoxic pain. J Pain Sympt Manage 35 (2008) 327-333
24. Patel S., Roshan V.R., Lee K.C., and Cheung R.J. A myoclonic reaction with low-dose hydromorphone. Ann Pharmocother 40 (2006) 2068-2070
25. Quill T.E., Dresser R., and Brock D.W. The rule of double effect: A critique of its role in end-of-life decision making. N Engl J Med 337 (1997) 1768-1771
26. Richmond C. Dame Cicely Saunders. Br Med J 33 (2005) 328
27. Ross J.R., Riley J., Taegetmeyer A.B., Sato H., Gretton S., du Bois R.M., and Welsh K.I. Genetic variation and response to morphine in cancer patients: Catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer 112 (2008) 1390-1403
28. Rousseau P. Existential suffering and palliative sedation: A brief commentary with a proposal for clinical guidelines. Am J Hosp Palliat Care 18 (2001) 151-153
29. Rousseau P.C. Palliative sedation and the fear of legal ramifications. J Palliat Med 9 (2006) 246-247
30. Sanjo M., Miyashita M., Morita T., Hirai K., Kawa M., Akechi T., and Uchitomi Y. Preferences regarding end-of-life cancer care and associations with good-death concepts: A population-based survey in Japan. Ann Oncol 18 (2007) 1539-1547
31. Sarhill N., Davis M.P., Walsh D., and Nouneh C. Methadone-induced myoclonus in advanced cancer. Am J Hosp Palliat Care 18 (2001) 51-53
32. Smith M.T. Neuroexcitatory effects of morphine and hydromorphone: Evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 27 (2000) 524-528